ProText Mobility Inc (TXTM)

[polochinos]

BIG DD TXTM ACQUISTION

Here is more information to catch everyone up to speed.

PROTEXT MOBILITY INC. ACQUISTION NEW 8-K

News Out!!!...The company is pleased to announced that it has reached an agreement to acquire Plandai Biotechnology South Africa (Plandai SA), a wholly owned subsidiary of Plandai Biotechnolgy, Inc (PLPL). Plandai SA is a biotechnology firm engaged in the research and development of botanical extracts, aimed at treating metabolic disorders, like diabetes & others. The parent company, Plandaí Biotechnology, Inc. is the culmination of over 10 years of R&D in the field of plant extracts with principle holdings including raw materials processing infrastructure, production facilities, farms and land totaling more than 7500 acres, in the province of Mpumalanga, South Africa.

Closing is expected to occur on or around January 2, 2017.

Additional Information about Plandai Biotechnolgy, Inc

Plandaí Biotechnology, Inc. and its subsidiaries develop highly bioavailable extracts. It controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company's products include cosmeceutical, wellness, anti-aging, pharmaceutical and animal husbandry.

MJ Research Endorsement in South Africa

December 8, 2016

Plandai Biotechnology, Inc. Announces South African Department of Health Endorses Access to Medicinal Cannabis

Roger Baylis-Duffield,
Chairman and Chief Executive Officer of Plandaí Biotechnology, stated, "We are pleased to see this change in the department's stance on medical cannabis and are looking forward to producing and testing our Phytofare® cannabinoid complex in the near future in South Africa.


Phytofare Technology and Exclusive Rights

Plandai Biotechnology, Inc., a producer of highly bioavailable plant extracts for industries including health, wellness, nutriceutical, and pharmaceutical, today announced that it has signed an exclusive agreement with North-West University in Potchefstroom, South Africa, that holds the patents and associated intellectual property associated with the entrapment of compounds in long-chain fatty acids-based nano- and micro-particles, known as Pheroid(R). Under the terms of the world license, Plandai has the exclusive right to use the Pheroid(R) technology with all Phytofare polyene-based extracts, which includes proprietary extracts of most botanical matter, for human and animal use.
The Pheroid(R) technology, developed for a number of applications by Professors Anne Grobler Awie Kotze and Jeanetta du Plessis of North-West University, allows particles to be encapsulated, or entrapped, in different media that can improve absorption through protecting the contents. It is actively used worldwide for industrial and agricultural purposes and has been extensively tested in humans and animals by Professor Grobler where it has shown an ability to significantly increase the level of absorption of the entrapped particles into the bloodstream.
For Plandai's purposes, the technology will enable the company to produce Phytofare topical products with significantly enhanced tissue absorption and oral products that can help Phytofare survive intact on its passage through the digestive tract and into the bloodstream. Once in the bloodstream, human cells perceive the Pheroid(R) material as a biological building block and as a source of energy, allowing them to pass through the cell membrane and, by metabolism of the long chain fatty acids, release the valuable phytonutrients directly to the tissues.

Plandai and FDA have existing relationship

links

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11750245

http://www.protextm.co

http://www.nasdaq.com/press-release/plandai-biotechnology-inc-announces-south-african-department-of-health-endorses-access-to-medicina-20161208-00205

https://www.accesswire.com/407406/Plandai-Biotechnology-Inc-Announces-License-Agreement-to-Acquire-Nano-and-Micro-Entrapment-Technology

http://www.nutraingredients-usa.com/Manufacturers/FDA-exemption-speeds-release-of-Plandai-s-catechin-supplement

This is just the start to the digging. TXTM